Dare Bioscience, Inc. (DARE) Free cash flow 2016–2025
Dare Bioscience, Inc. (DARE) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$10.3MFY2025 · since FY2016: -$907,299 → -$10.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.3M | -309.6% |
| FY2024 | $4.9M | +112.4% |
| FY2023 | -$39.5M | -117.5% |
| FY2022 | -$18.2M | +36.9% |
| FY2021 | -$28.8M | -14.0% |
| FY2020 | -$25.3M | -89.6% |
| FY2019 | -$13.3M | -29.5% |
| FY2018 | -$10.3M | -304.7% |
| FY2017 | -$2.5M | -180.0% |
| FY2016 | -$907,299 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More DARE financial trends
DARE RevenueDARE Net incomeDARE Net marginDARE Gross profitDARE Gross marginDARE Operating incomeDARE Operating marginDARE Operating cash flowDARE Capital expendituresDARE Return on equityDARE Stock buybacksDARE Dividends paidDARE Total assetsDARE Total liabilitiesDARE Shareholders’ equityDARE overview →